Navigation Links
VasoNova Inc. Announces Strategic Partnership With Navilyst Medical Inc.
Date:9/24/2010

MENLO PARK, Calif., Sept. 24 /PRNewswire/ -- VasoNova (VasoNova Inc., Menlo Park, California) announced a strategic partnership with Navilyst Medical Inc. (Navilyst Medical Inc., Marlborough, Massachusetts) today to distribute its VasoNova™ Vascular Positioning System™ VPS™ central venous catheter navigation technology.

Commenting on the partnership, Navilyst Senior Vice President, George Bourne said "Navilyst Medical is a market and technology leader in vascular access and fluid management with a long tradition of therapeutic innovation. Accurate catheter tip location is clinically beneficial to the patient and directly contributes to lowering healthcare costs. These two things are firmly aligned with our mission and reflected in our many other market leading innovations in vascular access. We are very excited to be bringing the VasoNova™ VPS™ catheter navigation technology to our customers. The combination of best-in-class central venous catheters from Navilyst and real time catheter tip positioning of this caliber from VasoNova provides the best possible solution to our clinicians and for our patients".    

Paul Molloy, President & Chief Executive Officer at VasoNova added, "VasoNova's VPS™ technology is the first real-time intra-vascular catheter navigation technology that does not require external metal detectors or viewing screens, nor subjective interpretation of ECG signals, and is capable of confirming precise catheter tip location using highly sophisticated anatomical location identification algorithms embedded in its technology. These location signatures are identified utilizing highly specific Doppler ultrasound characteristics combined with other patient data. The VasoNova™ VPS™ is compatible with all commonly used PICC and CVC catheters. Navilyst's world-class vascular access product offering is highly synergistic and together we offer clinicians unparalleled technological advantages".

VasoNova is a privately held company, founded in 2005 and has developed a completely unique central venous catheter navigation technology that allows real-time accurate confirmation of placement of PICC and CVC catheters in the lower one third of the superior vena cava, the optimal position for catheter tip location. More than ten million such catheters are placed in the United States each year.

Related link for more information: www.vasonova.com; www.navilyst.com


'/>"/>
SOURCE VasoNova Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , December 2, 2016 Persistence ... pacemaker market in its upcoming report titled, "Global Market Study on ... Declining CAGR of -1.4% between 2016 and 2024". The global ... in 2015 and this is likely to decline to ... the global cardiac pacemaker market is anticipated to exhibit ...
(Date:12/2/2016)... Research and Markets has announced the addition of the ... 2022" report to their offering. ... , The global ultrasound device ... expected to grow at a CAGR of 5.5% during 2016-2022. Based on ... the forecast period, a CAGR of 8.8% in the global market. Among ...
(Date:12/2/2016)... In the first ever attempt to include ... from C. sativa, the Hebrew University in Jerusalem, the ... II , the Universita` del Piemonte Orientale and Phytoplant ... and unified inventory of phytocannabinoids of different botanical origin. ... remarkable chemical and structural diversity of phytocannabinoids. As a ...
Breaking Medicine Technology:
(Date:12/2/2016)... , ... December 02, 2016 , ... Halfway through its ... has provided preventative dental services to more than 15,900 children 5 years old and ... LA pledged $38 million over a span of five years to Western University of ...
(Date:12/2/2016)... CA (PRWEB) , ... December 02, 2016 , ... For over twenty-four years, Doctors ... basis to help personal injury victims find high quality medical care. When the company ... Angeles area. Fast forward to present day and the now ten-page directory features a ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Center for Autism ... caregivers of those affected by autism spectrum disorder (ASD) and other developmental disabilities. The ... Maine, will give parents and other caregivers the opportunity to share stories and advice, ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet’s newest campaign, ... standing as living proof that attitude and determination can combine into the most ... spike around the holidays. This campaign will offer patients a new-found hope, by ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... new version of its SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite helps biobanks, clinical, ... through labeling, storing, shipping and disposal. The new version is a faster and ...
Breaking Medicine News(10 mins):